Authors: Attanasio, R Barausse, M Cozzi, R

Citation: R. Attanasio et al., GH/IGF-I normalization and tumor shrinkage during long-term treatment of acromegaly by lanreotide, J ENDOC INV, 24(4), 2001, pp. 209-216

Authors: Barausse, M Attanasio, R Dallabonzana, D Oppizzi, G Veronese, S Lasio, G Valentini, LG Cozzi, R

Citation: M. Barausse et al., From macroprolactinoma to concomitant ACTH-PRL hypersecretion with Cushing's disease, J ENDOC INV, 23(2), 2000, pp. 107-111

Authors: Cozzi, R Dallabonzana, D Attanasio, R Barausse, M Oppizzi, G

Citation: R. Cozzi et al., A comparison between octreotide-LAR and lanreotide-SR in the chronic treatment of acromegaly, EUR J ENDOC, 141(3), 1999, pp. 267-271

Authors: Attanasio, R Oppizzi, G Lodrini, S Dallabonzana, D Barausse, M Orlandi, P DaRe, N Cozzi, R

Citation: R. Attanasio et al., Neurosurgery restores late GH rise after glucose-induced suppression in cured acromegalics (vol 140, pg 23, 1999), EUR J ENDOC, 140(3), 1999, pp. 268-268

Authors: Attanasio, R Oppizzi, G Lodrini, S Dallabonzana, D Barausse, M Orlandi, P DaRe, N Cozzi, R

Citation: R. Attanasio et al., Neurosurgery restores late GH rise after glucose-induced suppression in cured acromegalics, EUR J ENDOC, 140(1), 1999, pp. 23-28

Authors: Cozzi, R Attanasio, R Barausse, M Dallabonzana, D Orlandi, P Da Re, N Branca, V Oppizzi, G Gelli, G

Citation: R. Cozzi et al., Cabergoline in acromegaly: a renewed role for dopamine agonist treatment?, EUR J ENDOC, 139(5), 1998, pp. 516-521